P8IP
ABCL icon

Pier 88 Investment Partners’s AbCellera Biologics ABCL Stock Holding History

Pier 88 Investment Partners’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Buy
120,100
+14,370
+14% +$51.7K 0.1% 84
2025
Q4 		$362K Sell
105,730
-3,140
-3% -$14K 0.08% 101
2025
Q3 		$548K Sell
108,870
-135,310
-55% -$596K 0.1% 88
2025
Q2 		$838K Buy
244,180
+390
+0.2% +$971 0.16% 58
2025
Q1 		$544K Buy
243,790
+6,890
+3% +$19.8K 0.1% 83
2024
Q4 		$694K Buy
236,900
+41,400
+21% +$115K 0.14% 62
2024
Q3 		$508K Buy
195,500
+33,880
+21% +$93.9K 0.11% 71
2024
Q2 		$478K Buy
161,620
+126,640
+362% +$479K 0.11% 79
2024
Q1 		$158K Buy
+34,980
New +$178K 0.04% 93

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return